Bellevue Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.5M Sell
130,517
-43,193
-25% -$5.79M 0.39% 51
2025
Q1
$11.7M Sell
173,710
-19,008
-10% -$1.28M 0.26% 67
2024
Q4
$12M Buy
192,718
+22,874
+13% +$1.43M 0.23% 76
2024
Q3
$26.7M Sell
169,844
-31,571
-16% -$4.96M 0.43% 66
2024
Q2
$30.3M Sell
201,415
-162,649
-45% -$24.5M 0.49% 57
2024
Q1
$26.9M Sell
364,064
-154,826
-30% -$11.4M 0.41% 70
2023
Q4
$41M Sell
518,890
-17,847
-3% -$1.41M 0.63% 52
2023
Q3
$29.4M Sell
536,737
-75,876
-12% -$4.15M 0.47% 62
2023
Q2
$51.4M Sell
612,613
-16,871
-3% -$1.42M 0.73% 41
2023
Q1
$47.7M Sell
629,484
-52,574
-8% -$3.98M 0.69% 50
2022
Q4
$42.1M Buy
682,058
+28,244
+4% +$1.74M 0.56% 58
2022
Q3
$27.3M Buy
653,814
+73,927
+13% +$3.09M 0.39% 68
2022
Q2
$18.2M Sell
579,887
-1,142
-0.2% -$35.9K 0.26% 89
2022
Q1
$15.7M Hold
581,029
0.18% 99
2021
Q4
$11.1M Hold
581,029
0.11% 112
2021
Q3
$19.2M Sell
581,029
-148,960
-20% -$4.93M 0.2% 103
2021
Q2
$24.2M Sell
729,989
-12,211
-2% -$405K 0.24% 101
2021
Q1
$30.8M Buy
742,200
+100,588
+16% +$4.17M 0.33% 89
2020
Q4
$12.8M Buy
641,612
+64,465
+11% +$1.28M 0.15% 111
2020
Q3
$7.95M Buy
577,147
+152,147
+36% +$2.1M 0.11% 116
2020
Q2
$7.62M Buy
+425,000
New +$7.62M 0.11% 116